BackAurinia Pharmaceuticals Overview

Aurinia Pharmaceuticals Operating Income

Operating Income for AUPH.

Quarterly Operating Income

$41.42M
↑ 89.6% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$124.49M
↑ 309.33% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin